The clinical research landscape is rapidly transforming. Instead of viewing patients as subjects, sponsors now use the patients’ input to help reduce the burden they face during trials ... site and ...

Verily, the life sciences company owned by Google parent Alphabet, has teamed up with Novartis, Sanofi, Otsuka, and Pfizer on a project that aims to speed up clinical trials. The four drugmakers ...

It also pledges a common approach to contacting patients about the opportunity to take part in research, and the establishment of clinical trial acceleration networks (CTANs) designed to speed up ...

We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to ...

Newcastle University scientists, supported by funding from Versus Arthritis, have created an innovative bioprinting method that produ ...

Icon has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes Icon the ...

Bispecific antibodies (BsAbs) have emerged as a transformative class of biologics, offering dual-targeting mechanisms that enhance therapeutic efficacy across oncology, autoimmune disorders, and ra | ...

--(BUSINESS WIRE)--Medable Inc., a leading provider of clinical development technology, announced that its eConsent and eCOA solutions ... clinical trials platform enhances speed, scale, and ...

BOSTON--(BUSINESS WIRE)--eClinical Solutions ... in clinical trials, the company zeroed in on helping their life sciences clients embrace innovation for operational efficiency and trial speed ...